Elevation of CA 19-9 in giant hydronephrosis induced by a renal calculus

Urology

Volumn 63, Issue 2, 2004, Pages 381-382

  Meyer, A ^b   Kausch, I ^a   Kruger S ^b   Fetscher, S ^b   Bohle A ^b   Jocham, D ^b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CA 19-9 ANTIGEN;

ABDOMINAL RADIOGRAPHY; ADULT; ANAMNESIS; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; GIANT HYDRONEPHROSIS; HISTOPATHOLOGY; HUMAN; HYDRONEPHROSIS; IMMUNOHISTOCHEMISTRY; KIDNEY FIBROSIS; KIDNEY TUBULE EPITHELIUM; LABORATORY DIAGNOSIS; NEPHRECTOMY; NEPHROLITHIASIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PYELONEPHRITIS; SCINTISCANNING; STAGHORN STONE; TREATMENT INDICATION;

EID: 1242341516     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urology.2003.10.048     Document Type: Article

References (4)

1. Steinberg W. The clinical utility of the CA 19-9 tumor-associated antigen. Am J Gastroenterol. 85:1990;350-355.
2. Hsu M., Raine L., Fanger H. The use of avidin biotin peroxidase complex (ABC) in immunoperoxidase techniques comparison between ABC and unlabelled antibody (PAP) procedure . J Histochem Cytochem. 29:1981;577-583.
3. Yoshimasu T., Maebeya S., Suzuma T., et al. Disappearance curves for tumor markers after resection of intrathoracic malignancies. Int J Biol Markers. 14:1999;99-105.
4. Suzuki K., Muraishi O., Tokue A. The correlation of serum carbohydrate antigen 19-9 with benign hydronephrosis. J Urol. 167:2002;16-20.